SCHEMBL337243

SCHEMBL337243

C=CCP(=O)(O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11656919 0.98
Acrylamide SCHEMBL27618659 0.88 ALDH1A1 (0.42)
Pyridine SCHEMBL27891399 0.83 TSHR (0.31)
SCHEMBL8949888 0.81 LPAR2 (0.31)
SCHEMBL1559671 0.79 LPAR2 (0.35)
SCHEMBL779137 0.78
SCHEMBL3956656 0.77
SCHEMBL2852900 0.77
SCHEMBL17733934 0.77
SCHEMBL31694401 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097126-B2 Aqueous composition and use thereof for paper production BASF SE (DE) 2012-01-17 US claimed
EP-1654419-B1 AQUEOUS COMPOSITION AND USE THEREOF FOR PAPER PRODUCTION BASF AG (DE) 2006-11-08 EP claimed
US-20060037725-A1 Aqueous composition and use thereof for paper production BASF AKTIENGESELLSCHAFT (DE) 2006-02-23 US claimed
US-20060024262-A1 Aqueous composition and use thereof for paper production BASF AKTIENGESELLSCHAFT (DE) 2006-02-02 US claimed
US-20030045705-A1 Backbone modified oligonucleotide analogues ISIS PHARMACEUTICALS, INC. 2003-03-06 US claimed
EP-1004593-A2 Backbone modified oligonucleotide analogues ISIS PHARMACEUTICALS, INC. (US) 2000-05-31 EP claimed
US-5610289-A Backbone modified oligonucleotide analogues ISIS PHARMACEUTICALS, INC. (US) 1997-03-11 US claimed
CN-1090290-A Multi-stage polymers with caustic solubility and alkali insoluble stages ROHM & HAAS (US) 1994-08-03 CN claimed
WO-2025111428-A1 METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
WO-2025111425-A1 A METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
WO-2025111424-A1 PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2025-05-30 WO disclosed
US-20250163646-A1 PARTICULATE VINYLAMINE COMPOSITIONS AND METHOD OF MAKING SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
US-20250163647-A1 METHOD FOR PRODUCTION OF VINYL CARBOXAMIDE CONTAINING POLYMERS IN PARTICULATE FORM SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
US-20250163194-A1 METHOD OF PRODUCING VINYLAMINE-CONTAINING POLYMERS SOLENIS TECHNOLOGIES, L.P. (US) 2025-05-22 US disclosed
WO-1994006808-A1 METHODS FOR THE SYNTHESIS OF PHOSPHONATE ESTERS AFFYMAX TECHNOLOGIES N.V. (AN) 1994-03-31 WO disclosed
EP-0586570-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES ISIS PHARMACEUTICALS, INC. (US) 1994-03-16 EP disclosed
EP-0586520-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 1994-03-16 EP disclosed
WO-1992020822-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGUES ISIS PHARMACEUTICALS, INC. (US) 1992-11-26 WO disclosed
WO-1992020823-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 1992-11-26 WO disclosed
US-4430453-A USING AMMONIUM SALTS OF PHOSPHORUS CONTAINING ACIDS AS ADDITIVE BAYER AKTIENGESELLSCHAFT (DE) 1984-02-07 US disclosed